Lumida
/PEP
⌘K
PepsiCo Inc

PepsiCo Inc

PEP
$136.32USD-0.24%-0.33 today

MARKET CAP

186.1B

P/E (TTM)

21.4x

FWD P/E

DAY RANGE

$136 – $137

52W RANGE

$134
$171

AI Summary

Stalk
TrimMedium

PEP remains entrenched in a Stage 4 downtrend, confirmed by sequential lower highs and lows beneath declining EMAs. The long- and medium-term biases are bearish, while short-term conditions are oversold and extended, suggesting a technical bounce rather than a reversal. We defer sell-side engagement, targeting rallies into the falling 9/20 EMAs or the broken 139–140 zone for rejection and continuation participation.

  • Q2 revenue rose 7% YoY to $24.18 B; EPS climbed 6% to $2.20
  • U.S. pricing strategy driving snack volume recovery despite inflation
  • Low earnings yield and negative growth indicators weaken valuation
Full analysis →

The case for & against

Bull & Bear analysis

Bullish

PepsiCo, Inc. (NASDAQ: PEP) is a dominant player in the food and beverage industry, known for its diverse portfolio of iconic brands, including Lay's, Tropicana, and Gatorade. The company operates across multiple segments, focusing significantly on snacks and beverages. In recent years, PepsiCo has been positioning itself to cater to the growing demand for healthier products while addressing macroeconomic challenges like inflation. The company’s strategic focus on affordability, innovation, and market adaptation reflects its responsiveness to changing consumer preferences, particularly in a time when economic pressures on consumers influence purchasing decisions.

Bull says

  • Q2 revenue rose 7% YoY to $24.18 B; EPS climbed 6% to $2.20
  • U.S. pricing strategy driving snack volume recovery despite inflation
  • Launched Doritos Protein and low-sugar Gatorade to meet health trends
  • International segment grew 7% YoY, adding profit-accretive scale
  • Dividend yield ~0.86% and moderate leverage support financial stability
  • M&A of Siete and Poppy integrated smoothly, broadening portfolio

Bear says

  • Low earnings yield and negative growth indicators weaken valuation
  • Analysts are lowering EPS forecasts, suggesting waning confidence
  • North America volumes stagnant, with gradual recovery slower than expected
  • Elevated short interest reflects skepticism over strategy execution
  • Heavy reliance on new health-focused products risks poor consumer uptake
  • Global inflation and geopolitical tensions may pressure margins

Investment themes with PEP

High Dividend Yield -0.51%

Companies paying above-average dividends

AVGO · JPM · XOM
Quality -0.56%

Companies with strong fundamentals and stability

NVDA · AAPL · MSFT
Food Products -1.01%

ADM · CTVA · KR

Earnings Call · Q2 2025 · Mgmt. Guidance

Updated 08-11-2026neutral

Transcript signals

Read full transcript analysis ›